AKT1 and hepatocellular carcinoma: PI3K/AKT signaling was activated in sorafenib-resistant HCC cells, and MK-2206 reversed the acquired resistance to sorafenib by reversing MDR in an EMT- dependent manner via downregulation of p-AKT.